Vol 2006, No 73 (2006)

Table of Contents

Cartoons

Deal termination jpg
Business Review Editor

Research & Development

Vical and AnGes Collaborate on Late-Stage Cancer Therapy. Abstract pdf
Business Review Editor
Innate Pharma Advances Toll-like Receptor Research Abstract pdf
Business Review Editor

Features

Novartis Looks to Combination Alliances to Strengthen its Hepatitis C Therapeutics Pipeline Abstract pdf
Business Review Editor
TorreyPines Chooses Consolidation over IPO Abstract pdf
Business Review Editor
Inhalation Technologies - A Breath of Fresh Air Abstract pdf
Business Review Editor
Technology Focus: DNA Microarrays Abstract pdf
Business Review Editor

Licensing

HGS Spin-off Licenses Technology from Parent Company Abstract
Business Review Editor

General

Galapagos Goes from Strength to Strength Abstract
Business Review Editor
Orexo AB Abstract pdf
Business Review Editor
MNLpharma Ltd Abstract
Business Review Editor

Distribution & Marketing

Genetic Technologies Enters into Agreements for Australian and Chinese Territories Abstract pdf
Business Review Editor

Business Commentaries

Challenging the Biotech Business Model Abstract html
Fintan Walton

Deal Trackers

Prestara (prasterone) Abstract pdf
Business Review Editor

Mergers & Acquisitions

Novozymes Acquires sanofi–aventis Subsidiary Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.